184 related articles for article (PubMed ID: 19735460)
1. Effect of the rho-kinase inhibitor hydroxyfasudil on bladder overactivity: an experimental rat model.
Masago T; Watanabe T; Saito M; Kinoshita Y; Sato K; Miyagawa I
Int J Urol; 2009 Oct; 16(10):842-7. PubMed ID: 19735460
[TBL] [Abstract][Full Text] [Related]
2. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
[TBL] [Abstract][Full Text] [Related]
3. Impact of Rho-Kinase Inhibitor Hydroxyfasudil in Protamine Sulphate Induced Cystitis Rat Bladder.
Akin Y; Bozkurt A; Erol HS; Halici M; Celebi F; Kapakin KA; Gulmez H; Ates M; Coban A; Nuhoglu B
Low Urin Tract Symptoms; 2015 May; 7(2):108-14. PubMed ID: 26663691
[TBL] [Abstract][Full Text] [Related]
4. Effects of the Rho kinase inhibitor, hydroxyfasudil, on bladder dysfunction and inflammation in rats with HCl-induced cystitis.
Shimizu N; De Velasco MA; Umekawa T; Uemura H; Yoshikawa K
Int J Urol; 2013 Nov; 20(11):1136-43. PubMed ID: 23419011
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyfasudil ameliorates bladder dysfunction in male spontaneously hypertensive rats.
Inoue S; Saito M; Takenaka A
Urology; 2012 May; 79(5):1186.e9-14. PubMed ID: 22365452
[TBL] [Abstract][Full Text] [Related]
6. Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model.
Eser N; Göçmen C; Erdoğan S; Büyüknacar HS; Kumcu EK; Açıkalın A; Önder S
Phytomedicine; 2012 Jun; 19(8-9):840-5. PubMed ID: 22647456
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis.
Ho DR; Chen CS; Lin WY; Chang PJ; Huang YC
Int J Urol; 2011 Jul; 18(7):525-31. PubMed ID: 21605172
[TBL] [Abstract][Full Text] [Related]
8. Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats.
Wróbel A; Doboszewska U; Rechberger E; Rojek K; Serefko A; Poleszak E; Skalicka-Woźniak K; Dudka J; Wlaź P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):613-619. PubMed ID: 28220212
[TBL] [Abstract][Full Text] [Related]
9. Effect of phosphodiesterase type 4 inhibitor rolipram on cyclophosphamide-induced cystitis in rats.
Büyüknacar HS; Kumcu EK; Göçmen C; Onder S
Eur J Pharmacol; 2008 May; 586(1-3):293-9. PubMed ID: 18358472
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reperfusion injury in canine coronary microcirculation in vivo.
Yada T; Shimokawa H; Hiramatsu O; Kajita T; Shigeto F; Tanaka E; Shinozaki Y; Mori H; Kiyooka T; Katsura M; Ohkuma S; Goto M; Ogasawara Y; Kajiya F
J Am Coll Cardiol; 2005 Feb; 45(4):599-607. PubMed ID: 15708710
[TBL] [Abstract][Full Text] [Related]
11. Involvement of orexin-A on micturition reflex in normal and cyclophosphamide-induced cystitis bladder in rat.
Kobayashi M; Nomura M; Fujihara H; Suzuki H; Otsubo H; Nishii H; Fujimoto N; Matsumoto T; Ueta Y
Peptides; 2009 Dec; 30(12):2348-56. PubMed ID: 19666069
[TBL] [Abstract][Full Text] [Related]
12. Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.
Chuang YC; Yoshimura N; Huang CC; Wu M; Chiang PH; Chancellor MB
Eur Urol; 2009 Jul; 56(1):159-66. PubMed ID: 18514386
[TBL] [Abstract][Full Text] [Related]
13. Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder.
Juszczak K; Ziomber A; Wyczółkowski M; Thor PJ
Can J Physiol Pharmacol; 2010 Sep; 88(9):899-906. PubMed ID: 20921976
[TBL] [Abstract][Full Text] [Related]
14. Effect of tamsulosin on bladder blood flow and bladder function in a rat model of bladder over distention/emptying induced bladder overactivity.
Okutsu H; Matsumoto S; Ohtake A; Suzuki M; Sato S; Sasamata M; Uemura H
J Urol; 2011 Dec; 186(6):2470-7. PubMed ID: 22019173
[TBL] [Abstract][Full Text] [Related]
15. Effect of the potassium channel opener WAY-133537 on the overactive bladder of spinalized rats.
Elzayat E; Khaled S; Kashiwabara T; Elhilali M; Corcos J
Neurourol Urodyn; 2006; 25(7):808-14. PubMed ID: 16804922
[TBL] [Abstract][Full Text] [Related]
16. Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
Yokoyama O; Miwa Y; Oyama N; Aoki Y; Ito H; Akino H
J Urol; 2007 Nov; 178(5):2208-12. PubMed ID: 17870108
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.
Holmström F; Shimizu S; Shimizu T; Higashi Y; Martin DT; Honda M; Saito M
Prostate; 2015 Nov; 75(15):1774-82. PubMed ID: 26286428
[TBL] [Abstract][Full Text] [Related]
18. Effects of opioid subtypes on detrusor overactivity in rats with cerebral infarction.
Nagasaka Y; Yokoyama O; Komatsu K; Ishiura Y; Nakamura Y; Namiki M
Int J Urol; 2007 Mar; 14(3):226-31; discussion 232. PubMed ID: 17430260
[TBL] [Abstract][Full Text] [Related]
19. Obstruction alters muscarinic receptor-coupled RhoA/Rho-kinase pathway in the urinary bladder of the rat.
Takahashi N; Shiomi H; Kushida N; Liu F; Ishibashi K; Yanagida T; Shishido K; Aikawa K; Yamaguchi O
Neurourol Urodyn; 2009; 28(3):257-62. PubMed ID: 19229948
[TBL] [Abstract][Full Text] [Related]
20. Functional, histological structure and mastocytes alterations in rat urinary bladders following acute and [corrected] chronic cyclophosphamide treatment.
Juszczak K; Gil K; Wyczolkowski M; Thor PJ
J Physiol Pharmacol; 2010 Aug; 61(4):477-82. PubMed ID: 20814076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
